Zheng Yidan, Xu Li, Cai Ziwen, Tu Jingrong, Liu Yuqi, Wang Yixuan, Chen Si, Dong Nianguo, Li Fei
Department of Cardiovascular Surgery, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, China.
Key Laboratory of Organ Transplantation, Ministry of Education, NHC Key Laboratory of Organ Transplantation, Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, Wuhan, China.
Front Cardiovasc Med. 2022 May 20;9:874133. doi: 10.3389/fcvm.2022.874133. eCollection 2022.
To evaluate the influence of transfusion amount of blood components on the prognosis of patients after heart transplantation (HTx).
From 1 January 2015 to 31 December 2020, 568 patients underwent HTx in our institute. A total of 416 recipients with complete datasets were enrolled in the study for final statistical analysis according to the inclusion criteria. The optimal cut-off values for intraoperative transfusion of red blood cell (RBC), platelet, and plasma were determined with receiver operating curve analysis. Univariate and multivariate Cox regression analyses were applied to compare baseline data of patients divided by the transfusion amounts of RBC, platelet, and plasma. Propensity score matching was used to enable the direct comparison of outcomes.
The Kaplan-Meier analysis revealed that transfusion amounts of RBC and plasma were independently associated with overall mortality, increased intensive care unit stay time, and major adverse events after transplantation. The multivariate Cox regression analysis suggested that neurological complications ( = 0.001), liver damage ( = 0.011), and respiratory complications ( = 0.044) were independent risk factors for overall mortality after HTx. Combining indicators presented a good predicting effect of peritransplant period mortality (AUC = 0.718).
The mortality of HTx was significantly related to the high-amount transfusion of RBC and plasma. Comprehensively considering the components of blood transfusion obtained better predictive results of peritransplant period survival than solely considering a single component.
评估血液成分输注量对心脏移植(HTx)术后患者预后的影响。
2015年1月1日至2020年12月31日,我院共有568例患者接受了心脏移植手术。根据纳入标准,共有416例具有完整数据集的受者被纳入本研究进行最终统计分析。通过受试者工作特征曲线分析确定术中红细胞(RBC)、血小板和血浆输注的最佳截断值。采用单因素和多因素Cox回归分析比较按RBC、血小板和血浆输注量分组的患者的基线数据。使用倾向评分匹配法对结果进行直接比较。
Kaplan-Meier分析显示,RBC和血浆的输注量与总体死亡率、重症监护病房停留时间延长以及移植后主要不良事件独立相关。多因素Cox回归分析表明,神经并发症(=0.001)、肝损伤(=0.011)和呼吸并发症(=0.044)是心脏移植术后总体死亡率的独立危险因素。联合指标对围移植期死亡率具有良好的预测效果(AUC=0.718)。
心脏移植的死亡率与RBC和血浆的大量输注显著相关。综合考虑输血成分比仅考虑单一成分能更好地预测围移植期生存率。